The Latest Breaking News from GSK

Shares of Korro Bio and Wave Life Sciences diverged Monday after an analyst argued Korro is the better way to play the RNA-editing space.

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the Federal Reserve's November meeting.

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

Moderna stock, which lost 27% of its value over two days, tumbled again Monday on a rare downgrade amid uncertainty for its vaccines.

Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

GSK stock fell early Wednesday on light sales of two key vaccines, Shingrix and Arexvy, though the company otherwise beat expectations.

This XDefiant factions guide helps players know what the different factions specialize in and what abilities they provide during combat.

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.